Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: In-vitro and in-vivo pharmacokinetic studies

Abruzzo, 2012, Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride, Carbohydr. Polym., 87, 581, 10.1016/j.carbpol.2011.08.024

Andrews, 2009, Mucoadhesive polymeric platforms for controlled drug delivery, Eur. J. Pharm. Biopharm., 71, 505, 10.1016/j.ejpb.2008.09.028

Badhan, 2009, Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection, AAPS PharmSciTech., 10, 459, 10.1208/s12249-009-9231-4

Baveja, 1988, Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry, Int. J. Pharm., 41, 55, 10.1016/0378-5173(88)90135-4

Blier, 2003, Is there a role for 5-HT1A agonists in the treatment of depression?, Biol. Psychiatry, 53, 193, 10.1016/S0006-3223(02)01643-8

Boyapally, 2010, Controlled release from directly compressible theophylline buccal tablets, Colloids Surf. B, 77, 227, 10.1016/j.colsurfb.2010.01.031

Charde, 2008, Development and evaluation of buccoadhesive controlled release tablets of lercanidipine, AAPS PharmSciTech., 9, 182, 10.1208/s12249-007-9031-7

Choi, 2000, Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva, J. Control. Release, 68, 397, 10.1016/S0168-3659(00)00276-5

Debord, 1987, Study of different crystalline forms of mannitol: comparative behaviour under compression, Drug Dev. Ind. Pharm., 13, 1533, 10.3109/03639048709068679

Giovino, 2012, Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules, Int. J. Pharm., 428, 143, 10.1016/j.ijpharm.2012.02.035

Gohel, 2009, Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate, Curr. Drug Deliv., 6, 486, 10.2174/156720109789941696

Gurny, 1982, Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers, Biomaterials, 3, 27, 10.1016/0142-9612(82)90057-6

Harris, 1992, Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci., 81, 1, 10.1002/jps.2600810102

Heng, 2001, Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets, J. Control. Release, 76, 39, 10.1016/S0168-3659(01)00410-2

Holgado, 1995, Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets, Int. J. Pharm., 118, 151, 10.1016/0378-5173(94)00317-X

Jaipal, 2013, Interaction of calcium sulfate with xanthan gum: effect on in vitro bioadhesion and drug release behavior from xanthan gum based buccal discs of buspirone, Colloids Surf., B, 111C, 644, 10.1016/j.colsurfb.2013.06.052

Jaipal, 2014, Controlled release effervescent buccal discs of buspirone hydrochloride: in-vitro and in-vivo evaluation studies, Drug Delivery, 1–7

Kianfar, 2013, Lyophilized wafers comprising carrageenan and pluronic acid for buccal drug delivery using model soluble and insoluble drugs, Colloids Surf. B, 103, 99, 10.1016/j.colsurfb.2012.10.006

Korsmeyer, 1983, Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air, J. Pharm. Sci., 72, 1189, 10.1002/jps.2600721021

Korsmeyer, 1983, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm., 15, 25, 10.1016/0378-5173(83)90064-9

Leung, 1990, Polymer structure features contributing to mucoadhesion. II, J. Control. Release, 12, 187, 10.1016/0168-3659(90)90099-F

Lilja, 1998, Grapefruit juice substantially increases plasma concentrations of buspirone[ast], Clin. Pharmacol. Ther., 64, 655, 10.1016/S0009-9236(98)90056-X

Mahmood, 1999, Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug, Clin. Pharmacokinet., 36, 277, 10.2165/00003088-199936040-00003

Martin, 2003, Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels, Eur. J. Pharm. Biopharm., 55, 35, 10.1016/S0939-6411(02)00118-2

Morishita, 2001, Pluronic® F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin, Int. J. Pharm., 212, 289, 10.1016/S0378-5173(00)00615-3

Muchohi, 2008, Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions, Br. J. Clin. Pharmacol., 66, 529, 10.1111/j.1365-2125.2008.03239.x

Mumtaz, 1995, Evaluation of bioadhesive buccal tablets containing triamcinolone acetonide in healthy volunteers, Int. J. Pharm., 121, 249, 10.1016/0378-5173(95)00058-Q

Nafee, 2004, Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation, Drug Dev. Ind. Pharm., 30, 985, 10.1081/DDC-200037245

Narendra, 2005, Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique, Int. J. Pharm., 304, 102, 10.1016/j.ijpharm.2005.07.021

Peppas, 1996, Hydrogels as mucoadhesive and bioadhesive materials: a review, Biomaterials, 17, 1553, 10.1016/0142-9612(95)00307-X

Pozzilli, 2005, Biokinetics of buccal spray insulin in patients with type 1 diabetes, Metabolism, 54, 930, 10.1016/j.metabol.2005.02.008

Ratey, 1989, Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons, J. Clin. Psychiatry, 50, 382

Realmuto, 1989, Clinical effect of buspirone in autistic children, J. Clin. Psychopharmacol., 9, 122, 10.1097/00004714-198904000-00009

Riblet, 1983, Buspirone: an anxioselective alternative for the management of anxiety disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, 7, 663, 10.1016/0278-5846(83)90042-8

Rossi, 2005, Buccal drug delivery: a challenge already won?, Drug Discov. Today Technol., 2, 59, 10.1016/j.ddtec.2005.05.018

Salamat-Miller, 2005, The use of mucoadhesive polymers in buccal drug delivery, Adv. Drug Deliv. Rev., 57, 1666, 10.1016/j.addr.2005.07.003

Sheikhzadeh, 2007, Quantitative and molecular analysis of buspirone hydrochloride polymorphs, J. Pharm. Sci., 96, 569, 10.1002/jps.20723

Smart, 2005, The basics and underlying mechanisms of mucoadhesion, Adv. Drug Deliv. Rev., 57, 1556, 10.1016/j.addr.2005.07.001

Sramek, 2002, Generalised anxiety disorder: treatment options, Drugs, 62, 1635, 10.2165/00003495-200262110-00005

Sudhakar, 2006, Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs, J. Control. Release, 114, 15, 10.1016/j.jconrel.2006.04.012

Taylan, 1996, Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets, J. Control. Release, 38, 11, 10.1016/0168-3659(95)00094-1

Taylor, 1985, Pharmacological and clinical effects of buspirone, Pharmacol. Biochem. Behav., 23, 687, 10.1016/0091-3057(85)90438-1

Yehia, 2008, Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release, AAPS PharmSciTech., 9, 1207, 10.1208/s12249-008-9166-1